SAN FRANCISCO — Drug companies here are rallying behind legislation that they say would fix a state consumer privacy law that threatens to jeopardize the integrity of clinical trial results and drive scientists out of California.

The bill, called SB-1121, would prevent patients from accessing and deleting some of their data from clinical trials. The idea is to make sure that clinical trial participants can’t use the consumer privacy law to prohibit their data from being used by researchers, or to find out if, say, they’re receiving an active treatment or a placebo.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This makes little sense.
    One of the very fundamental premises in human subject research is the subjects’ option to withdraw at any time and, likewise, to have their data expunged upon withdrawal.
    Why would CA want to pass a law that violates the foundations of protecting humans in a research environment? These rules and regulations are there to prevent negative effects on subjects and are part of the premise of weighing potential harm versus potential gain…and the ability to drop out and have your data expunged when you have left the study is an iomportant component in the subjects’ perception of well-being and trust in researchers

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy